Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system

Neuropharmacology

Volumn 57, Issue 7-8, 2009, Pages 715-721

  Lafenêtre, Pauline ^a   Chaouloff, Francis ^a   Marsicano, Giovanni ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Behavioral inhibition; Conditional mutagenesis; Endocannabinoid system; GABAergic transmission; Glutamatergic transmission; Impulsivity

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; FOOD INTAKE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; IMPULSIVENESS; INSTRUMENTAL CONDITIONING; MALE; MOUSE; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STIMULUS RESPONSE;

ANIMALS; ENDOCANNABINOIDS; EXPLORATORY BEHAVIOR; FOOD; GAMMA-AMINOBUTYRIC ACID; GENOTYPE; GLUTAMIC ACID; INHIBITION (PSYCHOLOGY); MALE; MICE; MICE, KNOCKOUT; NEURONS; REACTION TIME; RECEPTOR, CANNABINOID, CB1;

EID: 70350237015     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2009.07.014     Document Type: Article

References (42)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, DSM-IV (1994), American Psychiatric Association
2. Cloninger C.R. A systematic method for clinical description and classification of personality variants. Arch. Gen. Psychiatry 44 (1987) 573-588
3. Daruna J.H., and Barnes P.A. A neurodevelopmental view of impulsivity. In: McCown W.G., Johnson J.L., and Shure M.B. (Eds). The Impulsive Client: Theory, Research and Treatment (1993), American Psychological Association, Washington, D.C 23
4. De Wit H. Impulsivity as a determinant and consequence of drug use: a review of underlying processes. Addict. Biol. 14 (2009) 22-31
5. Dickman S.J. Functional and dysfunctional impulsivity: personality and cognitive correlates. J. Pers. Soc. Psychol. 58 (1990) 95-102
6. Di Marzo V., and Matias I. Endocannabinoid control of food intake and energy balance. Nat. Neurosci. 8 (2005) 585-589
7. Di Marzo V., Goparaju S.K., Wang L., Liu J., Batkai S., Jarai Z., Fezza F., Miura G.I., Palmiter R.D., Sugiura T., and Kunos G. Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410 (2001) 822-825
8. Ehlers C.L., Slutske W.S., Lind P.A., and Wilhelmsen K.C. Association between single nucleotide polymorphisms in the cannabinoid receptor gene (CNR1) and impulsivity in southwest California Indians. Twin Res. Hum. Genet. 10 (2007) 805-811
9. Evenden J.L. Varieties of impulsivity. Psychopharmacology (Berl.) 146 (1999) 348-361
10. Floresco S.B., Tse M.T., and Ghods-Sharifi S. Dopaminergic and glutamatergic regulation of effort- and delay-based decision making. Neuropsychopharmacology 33 (2008) 1966-1979
11. Kano M., Ohno-Shosaku T., Hashimotodani Y., Uchigashima M., and Watanabe M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89 (2009) 309-380
12. Krause J., Krause K.H., Dresel S.H., la F.C., and Ackenheil M. ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine. Dialogues Clin. Neurosci. 8 (2006) 29-36
13. Lafenetre P., Chaouloff F., and Marsicano G. The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction. Pharmacol. Res. 56 (2007) 367-381
14. Lane S.D., Cherek D.R., Tcheremissine O.V., Lieving L.M., and Pietras C.J. Acute marijuana effects on human risk taking. Neuropsychopharmacology 30 (2005) 800-809
15. Lee R., Petty F., and Coccaro E.F. Cerebrospinal fluid GABA concentration: relationship with impulsivity and history of suicidal behavior, but not aggression, in human subjects. J. Psychiatry Res. 43 (2009) 353-359
16. Lopez-Moreno J.A., Gonzalez-Cuevas G., Moreno G., and Navarro M. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction. Addict. Biol. 13 (2008) 160-187
17. Marsicano G., Goodenough S., Monory K., Hermann H., Eder M., Cannich A., Azad S.C., Cascio M.G., Gutierrez S.O., Van D., Lopez R., Casanova E., Schutz G., Zieglgänsberger W., Di Marzo V., Behl C., and Lutz B. CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
18. Marsicano, G., Kuner, R., 2008. Anatomical distribution of receptors, ligands and enzymes in the brain and in the spinal cord: circuitries neurochemistry. 161-201.
19. Marsicano G., and Lutz B. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11 (1999) 4213-4225
20. Marsicano G., and Lutz B. Neuromodulatory functions of the endocannabinoid system. J. Endocrinol. Invest. 29 (2006) 27-46
21. McDonald J., Schleifer L., Richards J.B., and De W.H. Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28 (2003) 1356-1365
22. Melis T., Succu S., Sanna F., Boi A., Argiolas A., and Melis M.R. The cannabinoid antagonist SR 141716A (rimonabant) reduces the increase of extra-cellular dopamine release in the rat nucleus accumbens induced by a novel high palatable food. Neurosci. Lett. 419 (2007) 231-235
23. Mirjana C., Baviera M., Invernizzi R.W., and Balducci C. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29 (2004) 1637-1647
24. Monory K., Blaudzun H., Massa F., Kaiser N., Lemberger T., Schutz G., Wotjak C.T., Lutz B., and Marsicano G. Genetic dissection of behavioural and autonomic effects of delta(9)-tetrahydrocannabinol in mice. PLoS Biol. 5 (2007) e269
25. Monory K., Massa F., Egertova M., Eder M., Blaudzun H., Westenbroek R., Kelsch W., Jacob W., Marsch R., Ekker M., Long J., Rubenstein J.L., Goebbels S., Nave K.A., During M., Klugmann M., Wolfel B., Dodt H.U., Zieglgansberger W., Wotjak C.T., Mackie K., Elphick M.R., Marsicano G., and Lutz B. The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 (2006) 455-466
26. Morgan B.E. Behavioral inhibition: a neurobiological perspective. Curr. Psychiatry Rep. 8 (2006) 270-278
27. Neal J.A., and Edelmann R.J. The etiology of social phobia: toward a developmental profile. Clin. Psychol. Rev. 23 (2003) 761-786
28. Newcorn J.H. New treatments and approaches for attention deficit hyperactivity disorder. Curr. Psychiatry Rep. 3 (2001) 87-91
29. Oades R.D. Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog. Brain Res. 172 (2008) 543-565
30. Pagotto U., Marsicano G., Cota D., Lutz B., and Pasquali R. The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr. Rev. 27 (2006) 73-100
31. Pattij T., Janssen M.C., Schepers I., Gonzalez-Cuevas G., De Vries T.J., and Schoffelmeer A.N. Effects of the cannabinoid CB1 receptor antagonist rimonabant on distinct measures of impulsive behavior in rats. Psychopharmacology (Berl.) 193 (2007) 85-96
32. Pattij T., and Vanderschuren L.J. The neuropharmacology of impulsive behaviour. Trends Pharmacol. Sci. 29 (2008) 192-199
33. Piomelli D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4 (2003) 873-884
34. Ramaekers J.G., Kauert G., van R.P., Theunissen E.L., Schneider E., and Moeller M.R. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31 (2006) 2296-2303
35. Solanto M.V. Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research. Behav. Brain Res. 130 (2002) 65-71
36. Soubrie P. Serotonergic neurons and behavior. J. Pharmacol. 17 (1986) 107-112
37. Van Laere K., Goffin K., Bormans G., Casteels C., Mortelmans L., de H.J., Grachev I., Vandenbulcke M., and Pieters G. Relationship of type 1 cannabinoid receptor availability in the human brain to novelty-seeking temperament. Arch. Gen. Psychiatry 66 (2009) 196-204
38. Winstanley C.A., Dalley J.W., Theobald D.E., and Robbins T.W. Fractionating impulsivity: contrasting effects of central 5-HT depletion on different measures of impulsive behavior. Neuropsychopharmacology 29 (2004) 1331-1343
39. Winstanley C.A., Eagle D.M., and Robbins T.W. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin. Psychol. Rev. 26 (2006) 379-395
40. Winstanley C.A., Theobald D.E., Dalley J.W., Cardinal R.N., and Robbins T.W. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb. Cortex 16 (2006) 106-114
41. Winstanley C.A., Theobald D.E., Dalley J.W., and Robbins T.W. Interactions between serotonin and dopamine in the control of impulsive choice in rats: therapeutic implications for impulse control disorders. Neuropsychopharmacology 30 (2005) 669-682
42. Wotjak C.T. Role of endogenous cannabinoids in cognition and emotionality. Mini Rev. Med. Chem. 5 (2005) 659-670